Guy P Nohra has sold stock and made no open-market buys since Jun 2020

Guy P. Nohra is a director of Bioventus Inc. (BVS) and a veteran life sciences investor and entrepreneur with more than three decades of experience funding and building medical technology and biopharmaceutical companies.( He serves on the Bioventus board of directors as an independent director and corporate insider, where his role includes oversight of strategy and governance and participation in equity-based compensation programs, as reflected in recent Form 4 filings reporting grants and vesting of restricted stock units in Bioventus Class A common stock.(

Nohra is best known as a co‑founder and managing partner of Alta Partners, a leading life sciences venture capital firm that has raised multiple funds and invested more than $2 billion across over 150 healthcare and life sciences companies since the mid‑1990s.( He has been involved in the funding and development of notable companies such as ATS Medical, Cutera, Innerdyne, R2 Technology, deCODE genetics, AcelRx, and Vesica, and has served on numerous boards, including USGI Medical (chairman), Vertiflex, ZS Pharma, Carbylan Biosurgery, PneumRx, and others.( Recognized as one of Silicon Valley’s more successful biotech venture capitalists, he was named to Forbes’ “Midas List” of top dealmakers.( Nohra holds a Bachelor’s degree from Stanford University and a Master of Business Administration from the University of Chicago Booth School of Business, credentials that underpin his long-standing leadership in life sciences investing and corporate governance.(

Written by Perplexity from public sources.